Radiation and immunotherapy: a synergistic combination
Anusha Kalbasi, … , Naomi Haas, Neha Vapiwala
Anusha Kalbasi, … , Naomi Haas, Neha Vapiwala
Published July 1, 2013
Citation Information: J Clin Invest. 2013;123(7):2756-2763. https://doi.org/10.1172/JCI69219.
View: Text | PDF
Clinical Review

Radiation and immunotherapy: a synergistic combination

Abstract

Immunotherapy can be an effective treatment for metastatic cancer, but a significant subpopulation will not respond, likely due to the lack of antigenic mutations or the immune-evasive properties of cancer. Likewise, radiation therapy (RT) is an established cancer treatment, but local failures still occur. Clinical observations suggest that RT may expand the therapeutic reach of immunotherapy. We examine the immunobiologic and clinical rationale for combining RT and immunotherapy, two modalities yet to be used in combination in routine practice. Preclinical data indicate that RT can potentiate the systemic efficacy of immunotherapy, while activation of the innate and adaptive immune system can enhance the local efficacy of RT.

Authors

Anusha Kalbasi, Carl H. June, Naomi Haas, Neha Vapiwala

×

Figure 2

The role of RT in induction of the antitumor immune response.

Options: View larger image (or click on image) Download as PowerPoint
The role of RT in induction of the antitumor immune response. At baselin...
At baseline, both the tumor immune microenvironment and the poor antigenicity of the tumor allow it to escape immune recognition. Targeted RT can induce increased antigenic expression, release pro-inflammatory cytokines (e.g., CXCL16) that recruit immune cells, promote antigen cross-presentation (HMGB-1 via TLR4), and induce tumor expression of death receptors. Anti-CTLA4–targeted immunotherapy can enhance the adaptive immune component by promoting antigen cross-presentation and T cell activation. Used together, RT and immunotherapy may have synergistic effects and may shift the tumor immune system balance toward elimination.